The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
Evaluation of the GORE® VIAFORT Vascular Stent for Treatment of Symptomatic Iliofemoral Venous Obstruction
Sponsor: W.L.Gore & Associates
Listed as NCT05489588, this NA trial focuses on Vein Disease and Vein Occlusion and remains actively recruiting participants. Sponsored by W.L.Gore & Associates, it has been updated 17 times since 2023, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
17 versions recorded-
Dec 2025 — Present [monthly]
Recruiting NA
-
Nov 2025 — Dec 2025 [monthly]
Recruiting NA
-
Sep 2025 — Nov 2025 [monthly]
Recruiting NA
-
Aug 2025 — Sep 2025 [monthly]
Recruiting NA
-
Jul 2025 — Aug 2025 [monthly]
Recruiting NA
▶ Show 12 earlier versions
-
May 2025 — Jul 2025 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Sep 2024 — May 2025 [monthly]
Active Not Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Recruiting NA
-
Mar 2024 — Apr 2024 [monthly]
Recruiting NA
-
Oct 2023 — Mar 2024 [monthly]
Recruiting NA
-
Sep 2023 — Oct 2023 [monthly]
Recruiting NA
-
Aug 2023 — Sep 2023 [monthly]
Recruiting NA
-
Jun 2023 — Aug 2023 [monthly]
Recruiting NA
-
Apr 2023 — Jun 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2022 — Apr 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- W.L.Gore & Associates
For direct contact, visit the study record on ClinicalTrials.gov .